FdaApplication
ANDA 215576
Identifiers
- fda_app_no: ANDA215576
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2022-04-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUCRALFATE | SUCRALFATE | 1GM | TABLET;ORAL |
1 product